by Talking Medicines | Jun 22, 2022
Global Business Report (GBR) have recently published “United States Life Sciences 2022” Report. It was published in partnership with BioNJ, Biocom California and CPHI. Jo Halliday ,CEO was asked to contribute to the report on the transformational...
by Talking Medicines | May 18, 2022
Last week (9-15 May) was Mental Health Awareness Week, and was founded 21 years ago by The Mental Health Foundation. The theme for this year is ‘loneliness’. The Mental Health Foundation says: “One in four adults feel lonely some or all of the time. There’s no single...
by Talking Medicines | Apr 7, 2022
The post-Covid world is unpredictable; there is little that hasn’t been touched by the pandemic. Whilst the “new normal” has many remnants of our old lives, there is a sense of unpredictability and vulnerability that we didn’t have to face...
by Talking Medicines | Feb 2, 2022
Talking Medicines, the world’s first Artificial Intelligence (AI) driven patient intelligence company designed to meet the needs of Pharma, has closed a £1.5 million funding round to support its ambitions plans for expansion into the US. Boston based life science...
by Talking Medicines | Dec 3, 2021
What would you say if I told you that customer experience is not what you think it is? Customer Experience is about chemicals, a chimp and the power of memories! Hear me out on this….. and let’s start with emotion. Understanding Emotions Before we dive into emotional...
by Talking Medicines | Nov 11, 2021
Big Data The volume of data in the world is increasing dramatically. According to United Nations, 64.2 zettabytes of data were created, that is a 314 percent increase from 2015. An increased demand for information due to the COVID-19 pandemics also contribute to...
